BridgeMD
Prevention study for Metabolic Syndrome
Official title Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women
ClinicalTrials.gov ID: NCT06827704
What this study is testing
- What it's testing
- This study aims to to improve physical activity and metabolic outcomes for breast cancer prevention in South Asian Indian immigrant women.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 65, women only. Healthy volunteers may be eligible.
You may be able to join if
- Self-identified first-generation SAI woman aged 40-65 years without breast cancer diagnosis (permanent residency in US or are in the process of...
- Insufficiently active (self-reported \<150 minutes/week of moderate-intensity or \<75 minutes/week of vigorous-intensity PA in the past month)
- Conversant in Hindi
- Owns a smartphone for Fitbit application
- Has a computer or mobile device with Internet access
You likely can't join if
- Major signs/symptoms of pulmonary or CVD, unstable cardiac or pulmonary disease in the past month, or other conditions interfering with walking (per...
- Systolic BP ≥160 and/or diastolic BP ≥100
See the full eligibility criteria
- Self-identified first-generation SAI woman aged 40-65 years without breast cancer diagnosis (permanent residency in US or are in the process of obtaining permanent residency)
- Insufficiently active (self-reported \<150 minutes/week of moderate-intensity or \<75 minutes/week of vigorous-intensity PA in the past month)
- Conversant in Hindi
- Owns a smartphone for Fitbit application
- Has a computer or mobile device with Internet access
- Willing to participate in recorded Virtual intervention sessions
- Medical clearance if has Type 1 diabetes, or Type 2 diabetes with an A1C ≥ 9.0%, or have an A1C of ≥ 6.5% without a prior diabetes diagnosis
- Has no disabilities preventing regular PA determined by Physical Activity Readiness Questionnaire (PAR-Q \& You)
- Major signs/symptoms of pulmonary or CVD, unstable cardiac or pulmonary disease in the past month, or other conditions interfering with walking (per PAR-Q \& You)
- Systolic BP ≥160 and/or diastolic BP ≥100
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
- Sugar Grove, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 40 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States; Sugar Grove, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.